MERISTEM THERAPEUTICS S A has a total of 12 patent applications. Its first patent ever was published in 1997. It filed its patents most often in EPO (European Patent Office), United States and Canada. Its main competitors in its focus markets biotechnology and pharmaceuticals are GENESIS RES AND DEVELOPMENT CORPORATION LIMITED, QUARK PHARMACEUTICALS INC and WELGENE INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 5 | |
#2 | United States | 4 | |
#3 | Canada | 3 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals |
# | Technology | |
---|---|---|
#1 | Microorganisms | |
#2 | Therapeutic chemical compounds | |
#3 | Peptides | |
#4 | Medical preparations | |
#5 | Microbiology |
# | Name | Total Patents |
---|---|---|
#1 | Merot Bertrand | 10 |
#2 | Bournat Philippe | 10 |
#3 | Gruber Veronique | 9 |
#4 | Garrone Robert | 4 |
#5 | Exposito Jean-Yves | 4 |
#6 | Legrand Dominique | 4 |
#7 | Comte Jeanne | 4 |
#8 | Salmon Valerie | 4 |
#9 | Ruggiero Florence | 4 |
#10 | Spik Genevieve | 4 |
Publication | Filing date | Title |
---|---|---|
EP1808491A1 | Genetically modified plant with modified storage protein content | |
EP1498475A1 | Continuous plant cell bioreactor and method for continuous plant cell culture |